BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21647296)

  • 1. Telomere dysfunction in human bone marrow failure syndromes.
    Shtessel L; Ahmed S
    Nucleus; 2011; 2(1):24-9. PubMed ID: 21647296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of Apollo (SNM1B) at telomere highlighted by a splice variant identified in a patient with Hoyeraal-Hreidarsson syndrome.
    Touzot F; Callebaut I; Soulier J; Gaillard L; Azerrad C; Durandy A; Fischer A; de Villartay JP; Revy P
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10097-102. PubMed ID: 20479256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
    Hoffman H; Rice C; Skordalakes E
    J Biol Chem; 2017 Mar; 292(11):4593-4601. PubMed ID: 28154186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
    Agarwal S
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
    Fok WC; Niero ELO; Dege C; Brenner KA; Sturgeon CM; Batista LFZ
    Stem Cell Reports; 2017 Aug; 9(2):409-418. PubMed ID: 28757166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita.
    Beier F; Foronda M; Martinez P; Blasco MA
    Blood; 2012 Oct; 120(15):2990-3000. PubMed ID: 22932806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskeratosis congenita, stem cells and telomeres.
    Kirwan M; Dokal I
    Biochim Biophys Acta; 2009 Apr; 1792(4):371-9. PubMed ID: 19419704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere dysfunction and hematologic disorders.
    Paiva RM; Calado RT
    Prog Mol Biol Transl Sci; 2014; 125():133-57. PubMed ID: 24993701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.
    Ballew BJ; Savage SA
    Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
    Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
    Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomeres and marrow failure.
    Calado RT
    Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential roles for Pot1b in HSC self-renewal and survival.
    Wang Y; Shen MF; Chang S
    Blood; 2011 Dec; 118(23):6068-77. PubMed ID: 21948176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere maintenance and human bone marrow failure.
    Calado RT; Young NS
    Blood; 2008 May; 111(9):4446-55. PubMed ID: 18239083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished telomeric 3' overhangs are associated with telomere dysfunction in Hoyeraal-Hreidarsson syndrome.
    Lamm N; Ordan E; Shponkin R; Richler C; Aker M; Tzfati Y
    PLoS One; 2009 May; 4(5):e5666. PubMed ID: 19461895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): why hypercellular marrow strongly favors accelerated apoptosis.
    Das M; Chaudhuri S; Law S
    Biochem Cell Biol; 2013 Oct; 91(5):303-8. PubMed ID: 24032679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous telomere defects in patients with severe forms of dyskeratosis congenita.
    Touzot F; Gaillard L; Vasquez N; Le Guen T; Bertrand Y; Bourhis J; Leblanc T; Fischer A; Soulier J; de Villartay JP; Revy P
    J Allergy Clin Immunol; 2012 Feb; 129(2):473-82, 482.e1-3. PubMed ID: 22078571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia.
    Bär C; Povedano JM; Serrano R; Benitez-Buelga C; Popkes M; Formentini I; Bobadilla M; Bosch F; Blasco MA
    Blood; 2016 Apr; 127(14):1770-9. PubMed ID: 26903545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited human Apollo deficiency causes severe bone marrow failure and developmental defects.
    Kermasson L; Churikov D; Awad A; Smoom R; Lainey E; Touzot F; Audebert-Bellanger S; Haro S; Roger L; Costa E; Mouf M; Bottero A; Oleastro M; Abdo C; de Villartay JP; Géli V; Tzfati Y; Callebaut I; Danielian S; Soares G; Kannengiesser C; Revy P
    Blood; 2022 Apr; 139(16):2427-2440. PubMed ID: 35007328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the telomere capping complex in bone marrow failure and related syndromes.
    Walne AJ; Bhagat T; Kirwan M; Gitiaux C; Desguerre I; Leonard N; Nogales E; Vulliamy T; Dokal IS
    Haematologica; 2013 Mar; 98(3):334-8. PubMed ID: 22899577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
    Polychronopoulou S; Koutroumba P
    Acta Haematol; 2004; 111(3):125-31. PubMed ID: 15034232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.